Concepedia

Paul Baskind

PB

Statistics

Publications

16

Citations

598

H-Index

14

Active since

1987

Affiliations

New York Medical College(Current)

Paul Baskind is an author at New York Medical College specializing in chemotherapy, medicine, and pharmacology.

Publications per year

1987–2018

16

Publications

16

Homoharringtonine in patients with myelodysplastic syndrome (MDS) and MDS evolving to acute myeloid leukemia.

Eric J. Feldman, Karen Seiter, T. Ahmed et al. · PubMed · 1996 · 79 citations

, , +14

Phase I clinical and pharmacokinetic evaluation of high-dose mitoxantrone in combination with cytarabine in patients with acute leukemia.

Eric J. Feldman, D S Alberts, Z Arlin et al. · Journal of Clinical Oncology · 1993 · 60 citations

, , +17

Amsacrine with high-dose cytarabine is highly effective therapy for refractory and relapsed acute lymphoblastic leukemia in adults

Arlin Za, Eric J. Feldman, Sanford Kempin et al. · Blood · 1988 · 58 citations · Full text

, , +12

Homoharringtonine is safe and effective for patients with acute myelogenous leukemia.

Eric J. Feldman, Z Arlin, Tamjeed Ahmed et al. · PubMed · 1992 · 54 citations

, , +5

Phase I Study of Temozolomide in Relapsed/Refractory Acute Leukemia

Karen Seiter, Delong Liu, Thomas P. Loughran et al. · Journal of Clinical Oncology · 2002 · 51 citations

, , +17

1–5 of 16